Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study.

Rumley CN, Lee MT, Holloway L, Rai R, Min M, Forstner D, Fowler A, Liney G.

BMC Cancer. 2017 Jul 10;17(1):475. doi: 10.1186/s12885-017-3448-5.

2.

Contemporary Diagnostic Imaging of Oral Squamous Cell Carcinoma - A Review of Literature.

Pałasz P, Adamski Ł, Górska-Chrząstek M, Starzyńska A, Studniarek M.

Pol J Radiol. 2017 Apr 7;82:193-202. doi: 10.12659/PJR.900892. eCollection 2017. Review.

3.

Comparison of DCE-MRI kinetic parameters and FMISO-PET uptake parameters in head and neck cancer patients.

Simoncic U, Leibfarth S, Welz S, Schwenzer N, Schmidt H, Reischl G, Pfannenberg C, Fougère C, Nikolaou K, Zips D, Thorwarth D.

Med Phys. 2017 Jun;44(6):2358-2368. doi: 10.1002/mp.12228. Epub 2017 Apr 20.

4.
5.

Multimodality functional imaging using DW-MRI and 18F-FDG-PET/CT during radiation therapy for human papillomavirus negative head and neck squamous cell carcinoma: Meixoeiro Hospital of Vigo Experience.

Aramburu Núñez D, Lopez Medina A, Mera Iglesias M, Salvador Gomez F, Dave A, Hatzoglou V, Paudyal R, Calzado A, Deasy JO, Shukla-Dave A, Muñoz VM.

World J Radiol. 2017 Jan 28;9(1):17-26. doi: 10.4329/wjr.v9.i1.17.

6.

Modelling tumour volume variations in head and neck cancer: contribution of magnetic resonance imaging for patients undergoing induction chemotherapy.

Dinapoli N, Tartaglione T, Bussu F, Autorino R, Miccichè F, Sciandra M, Visconti E, Colosimo C, Paludetti G, Valentini V.

Acta Otorhinolaryngol Ital. 2017 Feb;37(1):9-16. doi: 10.14639/0392-100X-906.

7.

Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck.

Welsh L, Panek R, Riddell A, Wong K, Leach MO, Tavassoli M, Rahman D, Schmidt M, Hurley T, Grove L, Richards T, Koh DM, Nutting C, Harrington K, Newbold K, Bhide S.

Br J Cancer. 2017 Jan 3;116(1):28-35. doi: 10.1038/bjc.2016.386. Epub 2016 Nov 24.

PMID:
27884018
8.

Dynamic contrast-enhanced magnetic resonance imaging for pretreatment prediction of early chemo-radiotherapy response in larynx and hypopharynx carcinoma.

Guo W, Luo D, Chen X, Lin M, Li L, Zhao Y, Yang L, Hu L, Zhao X, Zhou C.

Oncotarget. 2017 May 16;8(20):33836-33843. doi: 10.18632/oncotarget.12952.

10.

Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations.

King AD, Thoeny HC.

Cancer Imaging. 2016 Aug 19;16(1):23. doi: 10.1186/s40644-016-0080-6. Review.

11.

Applications and limitations of radiomics.

Yip SS, Aerts HJ.

Phys Med Biol. 2016 Jul 7;61(13):R150-66. doi: 10.1088/0031-9155/61/13/R150. Epub 2016 Jun 8.

12.

Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer.

Jansen JF, Lu Y, Gupta G, Lee NY, Stambuk HE, Mazaheri Y, Deasy JO, Shukla-Dave A.

World J Radiol. 2016 Jan 28;8(1):90-7. doi: 10.4329/wjr.v8.i1.90.

13.

DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.

King AD, Chow SK, Yu KH, Mo FK, Yeung DK, Yuan J, Law BK, Bhatia KS, Vlantis AC, Ahuja AT.

PLoS One. 2015 Dec 10;10(12):e0144770. doi: 10.1371/journal.pone.0144770. eCollection 2015.

14.

Evaluation of Head and Neck Tumors with Functional MR Imaging.

Jansen JF, Parra C, Lu Y, Shukla-Dave A.

Magn Reson Imaging Clin N Am. 2016 Feb;24(1):123-33. doi: 10.1016/j.mric.2015.08.011. Review.

15.

Functional imaging for radiotherapy treatment planning: current status and future directions-a review.

Thorwarth D.

Br J Radiol. 2015 Jul;88(1051):20150056. doi: 10.1259/bjr.20150056. Epub 2015 Apr 1. Review.

16.

Diagnosis of brain tumors using dynamic contrast-enhanced perfusion imaging with a short acquisition time.

Abe T, Mizobuchi Y, Nakajima K, Otomi Y, Irahara S, Obama Y, Majigsuren M, Khashbat D, Kageji T, Nagahiro S, Harada M.

Springerplus. 2015 Feb 24;4:88. doi: 10.1186/s40064-015-0861-6. eCollection 2015.

17.

Improving tumour heterogeneity MRI assessment with histograms.

Just N.

Br J Cancer. 2014 Dec 9;111(12):2205-13. doi: 10.1038/bjc.2014.512. Epub 2014 Sep 30. Review.

18.

Amide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer.

Yuan J, Chen S, King AD, Zhou J, Bhatia KS, Zhang Q, Yeung DK, Wei J, Mok GS, Wang YX.

NMR Biomed. 2014 Oct;27(10):1239-47. doi: 10.1002/nbm.3184. Epub 2014 Aug 19.

19.

Parametric contrast-enhanced ultrasound as an early predictor of radiation-based therapeutic response for lymph node metastases of nasopharyngeal carcinoma.

Ye Z, Huang P, Zhou X, Huang Q, Hu Q, Shui Y, Shen L, Lai E, Wei Q.

Mol Clin Oncol. 2014 Sep;2(5):666-672. Epub 2014 Jun 27.

20.

Advances in the management of squamous cell carcinoma of the head and neck.

Machiels JP, Lambrecht M, Hanin FX, Duprez T, Gregoire V, Schmitz S, Hamoir M.

F1000Prime Rep. 2014 Jun 2;6:44. doi: 10.12703/P6-44. eCollection 2014. Review.

Supplemental Content

Support Center